doi: 10.2337/dbi18-0008 7 NogueirasR
What about safety
Most side effects are short-term and improve as your body adjusts, especially with gradual dose increases
Specifically, there were lower rates of all-cause mortality and substantially fewer hospitalizations and emergency department visits. GLP-1 receptor agonists and dual GLP-1/GIP agonists have rapidly transformed the treatment landscape for Type 2 diabetes and obesity
Multiple physiological effects of GLP-1[1] Medications for diabetes comprise either GLP-1 receptor agonists, with short (one or two daily injections: Exenatide, Liraglutide, Lixisenatide) or long duration (one injection once weekly: extended-released Exenatide, Albiglutide, Dulaglutide, Taspoglutide)
If you want to understand what these medications actually do and how they work, see our full guide to what is GLP-1